NASDAQ$QDEL
Quidel Corp · Q1 2026 earnings
Q1 2026 earnings · · After market close · Investor relations
Briefing
QuidelOrtho reported Q1 2026 total revenues of $619.8M (-11% YoY) and a net loss of $91.8M, or $1.35 diluted EPS, on weaker respiratory and Joint Business headwinds.
Total revenues fell 11% to $619.8 million for the quarter ended March 29, 2026, as respiratory assay sales declined and the terminated Joint Business reduced Labs revenue. Net loss widened to $91.8 million, or $1.35 per share, from $12.7 million; cost of sales rose to 57.4% of revenue on mix and compensation.
- Total revenues $619.8M (-11% YoY).
- Respiratory products 11% of revenue vs 17% prior year.
- Net loss $91.8M; diluted EPS $(1.35).
- Labs revenue down on Joint Business termination ($13.3M impact).
Headline financials
Revenue & EPS history
Quidel · Revenue · Quarterly
$620M
Forward guidance
The 10-Q does not provide numeric consolidated annual EPS guidance for QDEL. Management commentary in MD&A covers costs, capital, and sector-specific risks.
Tailwinds
- Management discusses operational priorities and liquidity in the quarterly filing.
- Segment or product trends are disclosed where applicable to the business model.
Headwinds
- Macro, input-cost, and interest-rate exposure can affect near-term results.
- One-time items, impairments, or fair-value marks may distort quarterly comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 12 quarterly earnings reports · overlaid with Q1 2026
-3.1%
Avg return
Earnings day
-0.1%
Avg return
5 days after
+0.8%
Avg return
30 days after
17%
2 / 12 earnings
Positive
+6.9%
Q2 2024
Best reaction
-17.6%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -6.0% | -14.8% | +22.8% | |
| Q4 2025 | -17.6% | -19.7% | -40.6% | |
| Q3 2025 | -4.3% | +6.3% | +30.6% | |
| Q1 2025 | -0.3% | +44.3% | +13.8% | |
| Q3 2024 | -2.8% | +3.0% | -4.4% | |
| Q2 2024 | +6.9% | +2.0% | +7.5% | |
| Q1 2024 | -2.7% | -4.0% | -5.0% | |
| Q3 2023 | -0.9% | +2.9% | +13.3% | |
| Q2 2023 | -2.0% | -7.1% | -9.8% | |
| Q1 2023 | -6.5% | -7.7% | -7.6% | |
| Q3 2022 | +3.8% | +0.1% | +7.7% | |
| Q2 2022 | -5.1% | -6.3% | -19.2% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro